Evidence map›Paper›PMID 41801321›Full record

ArticleCEN case reports2026

A case of autosomal dominant polycystic kidney disease with multiple bilateral spontaneous retroperitoneal hemorrhages.

Masato Mizuta, Tatsuya Suwabe, Yuki Oba, Akinari Sekine, Masayuki Yamanouchi, Hiroki Mizuno, Eiko Hasegawa, Takehiko Wada, Makoto Fukuda, Motoaki Miyazono and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masato MizutaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan. mamoyou12@gmail.com.ORCID 0009-0003-8343-7653
Tatsuya SuwabeNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Yuki ObaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Akinari SekineNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Masayuki YamanouchiNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Hiroki MizunoNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Eiko HasegawaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Takehiko WadaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Makoto FukudaDepartment of Nephrology, Saga University Internal Medicine, Saga, Japan.
Motoaki MiyazonoDepartment of Nephrology, Saga University Internal Medicine, Saga, Japan.
Naoki SawaNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.
Yoshifumi UbaraNephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kawasaki, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We experienced a 45-year-old male with ADPKD who developed spontaneous retroperitoneal hemorrhages with hypertension in the right subcapsular renal space without trauma. After his condition worsened with conservative management, he was treated by renal transarterial embolization (TAE). Over the next eight years, he experienced bilateral bleeding at three different sites and underwent repeated endovascular treatment with renal TAE to stop the bleeding. After the fourth occurrence, the patient underwent hemodialysis. Although renal cysts and urinary tract bleeding occur frequently in ADPKD, retroperitoneal hemorrhage is rare; however, TAE is both effective and a good way to preserve renal function.

Indexed as

Embolization, TherapeuticHemorrhagePolycystic Kidney, Autosomal DominantHematomaHumansHypertensionKidneyMaleMiddle AgedRenal DialysisRetroperitoneal SpaceTomography, X-Ray ComputedTreatment OutcomeAutosomal polycystic kidney disease (ADPKD)Bilateral spontaneous retroperitoneal bleedingPerinephric hematomaSubcapsular renal hematomaTransarterial embolization (TAE)

Identifiers

PMID41801321
PMCPMC12972201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.